• PHP96 Mitigating Emergency Department Over-Crowding Utilizing Focused Operations Management Tools

    Nov 1, 2011, 00:00

  • PCV125 The Increasing Burden of Atrial Fibrillation on Health Care in Scotland

    Nov 1, 2011, 00:00

  • PCV121 The Economic and Humanistic Burden of Acute Coronary Syndrome (ACS)- A Systematic Review

    Nov 1, 2011, 00:00

  • PIH35 The Measurement and Valuation of Health Status Using EQ-5D in Brazil- A Systematic review

    Nov 1, 2011, 00:00

  • PMH69 Deprivation and Use of Atipycal Antipsychotics in Schizophrenia

    Nov 1, 2011, 00:00

  • HT1 Effectiveness, Efficiency and Budget Impact Affect The Belgian Drug Reimbursement Decision (DRD)

    Nov 1, 2011, 00:00

  • PMS42 Cost-Effectiveness of Increasing Bisphosphonates Adherence for Osteoporosis in Community Pharmacies

    Nov 1, 2011, 00:00

  • Editorial Board

    Nov 1, 2011, 00:00

  • PMD34 Cost Effectivness of Ambulatory Cardiac Monitor versus Holter

    Nov 1, 2011, 00:00

  • PHP135 Evaluation of Cost Containment Interventions Introduced on the Community Drug Schemes in Ireland Using A National Prescrption Claims Database

    Nov 1, 2011, 00:00

  • PSY48 Health-related Quality of Life in Russian Patients With Inhibitor Hemophilia

    Nov 1, 2011, 00:00

  • PND16 Health Economics of Sclerosis Multiplex in Slovakia

    Nov 1, 2011, 00:00

  • PDB75 Analysis of the Medicines Pricing Procedure in the Republic of Macedonia

    Nov 1, 2011, 00:00

  • PMH57 Association of Antidepressant-Related Weight Gain with Degree of Enjoyment and Satisfaction Regarding General Daily Activities, Medication and Overall Quality of Life

    Nov 1, 2011, 00:00

  • PMH50 Differences Between Opioid Dependent Patients in Italy and Germany Receiving Substitution Therapy

    Nov 1, 2011, 00:00

  • PHP153 Some Shortages and Alternatives to the Patent System for Pharmaceuticals

    Nov 1, 2011, 00:00

  • PCN182 What Kind of Changes Did the Publication of Two Large-Scale RCTs Lead to in Prostate Cancer Screening Guidelines?

    Nov 1, 2011, 00:00

  • PND58 A Real World Evaluation of the Time Associated with Administration of A Single Episode of Treatment in Patients with Hereditary Angioedema (HAE) in the Home and Hospital Environment

    Nov 1, 2011, 00:00

  • PMS48 Cost-Utility of Denosumab for the Treatment of Postmenopausal Osteoporosis in Spain

    Nov 1, 2011, 00:00

  • PMD7 Effectiveness and Self-Monitoring of Blood Glucose (SMBG) Frequencies in Poorly-Controlled Patients with Non-insulin-Treated Diabetes (NITDM) Who Were Not Active Testers Prior to the Step Study

    Nov 1, 2011, 00:00

  • PGI1 incidence and Cost of Treatment-Emergent Comorbid Events in an Insured Population Receiving Treatment for Chronic Hepatitis C (CHC) Virus Infection

    Nov 1, 2011, 00:00

  • PSS34 Qualitative Grounding for A New Patient Assessment Measure in Ophthalmology- The Functional Assessment of Visual Tasks (Vistas)

    Nov 1, 2011, 00:00

  • PCN201 Cost-Effectiveness Literature on Cancer Therapies, Trends and the Influence of Industry Involvement on Outcomes

    Nov 1, 2011, 00:00

  • PUK8 Chronic Kidney Disease Burdens Patients, Health Care Systems, and Employers

    Nov 1, 2011, 00:00

  • PCV134 Concomitant Medciation Use in US Adults on Statin Therapy- Findings from a Multi-Employer Claims Database

    Nov 1, 2011, 00:00

  • PRS1 Budget Impact analysis of Fluticasone Furoate (FFNS) in Treatment of Allergic Rhinitis Patients in Mexico

    Nov 1, 2011, 00:00

  • PCN180 Threshold Values for Cost-Effectiveness in AHTAPol and NICE for Cancer Drug Technologies

    Nov 1, 2011, 00:00

  • PRM50 Sample Size and Ethical Considerations in Randomized Cluster Sampling Versus Individual Patient Recruitment Formulas in Prospective Observational Studies

    Nov 1, 2011, 00:00

  • PMH62 An Examination of the Association Between Antidepressant-Related Weight Gain and Various Aspects of Worker Productivity

    Nov 1, 2011, 00:00

  • PMH52 Relationship Between Psychopathology and Self-Rated EQ-5D Health States Among Patients With Schizophrenia

    Nov 1, 2011, 00:00

  • PCN98 Estimating the Potential Cost-Effectiveness of Human Papillomavirus (HPV) Vaccination in Germany Using A Dynamic Transmission Model

    Nov 1, 2011, 00:00

  • PIH65 What Are We Missing in Meningococcal Disease Modelling to Better Understand the Health and Economic Impact of New Vaccines?

    Nov 1, 2011, 00:00

  • PGI24 Burden of Gastroesophageal Reflux Disease Among Patients With Persistent Symptoms Despite Proton Pump Inhibitor Therapy- An Observational Study in France

    Nov 1, 2011, 00:00

  • PCV112 A Comparison of European Health Care Systems on Stroke Prevention in Atrial Fibrillation – Interim Results of a Patient Satisfaction Survey

    Nov 1, 2011, 00:00

  • PMD38 Cost-Effectiveness of the Cardiovascular Marker ST2 in Providing Risk Stratification After Acute Heart Failure

    Nov 1, 2011, 00:00

  • PIH31 Anti-Viral Treatment of Chronic Hepatitis C in a Paediatric Population- A Cost-Effectiveness Analysis

    Nov 1, 2011, 00:00

  • PHP24 How Does the Committee to Evaluate Drugs (CED) Make Decisions about Ambulatory Pharmaceutical Funding in Ontario?

    Nov 1, 2011, 00:00

  • PHP124 Personalized Decision Making in Cancer Medicine? Systematic Overview of HTA Procedures and Specific Approaches in Ten Countries Across Four Continents

    Nov 1, 2011, 00:00

  • PIN51 A Cost-Effectiveness Analysis of Linezolid Versus Vancomycin for Ventilator-Associated Pneumonia Patients in Panama

    Nov 1, 2011, 00:00

  • PCN118 Consumption of Antineoplastic Agents in Slovak Republic Within Period of 2006-2010

    Nov 1, 2011, 00:00

  • PSS36 Demonstrating Conceptual Equivalen Translation of the Cu-Q2Ol From Italian into English

    Nov 1, 2011, 00:00

  • PMD23 Characterization of Focal Liver Lesions by Contrast-Enhanced Ultrasound in the Netherlands- An Economic Evaluation

    Nov 1, 2011, 00:00

  • PHP74 Considerable Potential Savings from Change in Distribution Channel for Serious Diseases Products in Gree The Case of OGA Social Security Fund (SSF)

    Nov 1, 2011, 00:00

  • MA1 Mapping the EQ-5D Index from I-QOL in Idiopathic and Neurogenic OAB Patients- Results from A Cross-Sectional Study in the United States and Four European Countries

    Nov 1, 2011, 00:00

  • PCV47 Analysis of Transient Ischemic Attack-Related Clinical Outcomes, Health Care Utilization and Cost Burden of Patients with Non-Valvular Atrial Fibrillation

    Nov 1, 2011, 00:00

  • PMH37 Cost-Minimisation Analysis of Asenapine Monotherapy Versus Other Antipsychotics in Bipolar I Disorder in Two Nordic Countries

    Nov 1, 2011, 00:00

  • PCN55 The Economic Burden of Adjuvant Chemotherapy in Germany

    Nov 1, 2011, 00:00

  • PDB2 Calidad De Prescripcion De Hipoglucemiantes orales En Una Unidad Medica Familiar- Centro, Tabasco, MÉxico, 2009

    Nov 1, 2011, 00:00

  • PMH2 The COST-Effectiveness Of Paliperidone Palmitate Compared To Olanzapine Pamoate In The Treatment Of Schizophrenia In Sweden

    Nov 1, 2011, 00:00

  • PRS2 Costos De atencion Medica atribuibles Al Consumo De Tabaco En México

    Nov 1, 2011, 00:00

  • PCN165 A First Estimate of the Incremental Impact of Males HPV Vaccination on HPV-Related Diseases in Europe

    Nov 1, 2011, 00:00

  • PDB20 A1C Variability and the Risk of Developing New Diabetes for the Healthy Adults in Japan

    Nov 1, 2011, 00:00

  • PMS34 Cost-Effectiveness Analysis of Bio- Hyaluronic Acid (HA) in Patients with Knee Osteoarthritis in Mexico

    Nov 1, 2011, 00:00

  • PCV15 Guidelines Adherence and Hypertension Control in Patients Suffering from Cardiovascular Disease

    Nov 1, 2011, 00:00

  • PMH77 Prescription Pattern Evaluation for Bipolar Disorder in a Treatment Facility in India

    Nov 1, 2011, 00:00

  • PSS10 Economic Outcomes of Glaucoma Treatment With Prostaglandin Eye Drops Preserved With Polyquad® Instead of Benzalkonium Chloride in Germany

    Nov 1, 2011, 00:00

  • PRM12 An Application of a Proposed Framework for Formulary Listing in Low-income Countries- Case of Côte d'Ivoire

    Nov 1, 2011, 00:00

  • PDB49 Resource Use in Patients with Type 2 Diabetes (T2D) Who Initiated Exenatide BID (EXBID) or Starter Insulin (INS) Therapy- 6-Month Data from Choice

    Nov 1, 2011, 00:00

  • PHP64 Reorganisation of Hospital Emergency Services- A Business Case for Quality Improvement

    Nov 1, 2011, 00:00

  • PCN94 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in the IMSS (Mexican Institute of Social Security)

    Nov 1, 2011, 00:00

  • AD3 Assessing The Compliance And Persistence of Allergen Immunotherapy In Allergic Rhinitis Using A Retrospective Pharmacy Database From The Netherlands

    Nov 1, 2011, 00:00

  • PSY31 Cost-Effectiveness of Tapentadol Prolonged-Release (Pr) Compared to Oxycodone Controlled Release (Cr) in Patients with Chronic Severe Non-Cancer Pain in Ireland

    Nov 1, 2011, 00:00

  • PMD84 Assessing Cost Effectiveness and Value of Further Research When Data are Sparse- Negative Pressure Wound Therapy for Severe Pressure Ulcers

    Nov 1, 2011, 00:00

  • PIH4 A Comparative Study of Respiratory Syncytial Virus (RSV) Prophylaxis in Premature Infants

    Nov 1, 2011, 00:00

  • PCV59 Annual Medical Expenditure and Mortality Related to Acute Coronary Syndrome (ACS) in the United Kingdom – A Systematic Review

    Nov 1, 2011, 00:00

  • PIN24 Potential Costs Associated with New Direct Acting Antiviral (DAAs) Therapy for Untreated Chronic Hepatitis C Genotype 1 Infection in the Veterans Health Administration

    Nov 1, 2011, 00:00

  • PIN59 A Cost-Effectiveness Analysis of Voriconazol, Anfotericine B and Caspofungin for Invasive Aspergilosis Patients in Panama

    Nov 1, 2011, 00:00

  • PND61 Impact of Patient Cost-Sharing Arrangements for Disease Modifying Therapies on Treatment Compliance among Patients with Multiple Sclerosis in the United States

    Nov 1, 2011, 00:00

  • PCN1 Selecting a Mix of Prevention Strategies Against Cervical Cancer for Maximum Efficiency with an Optimisation Program

    Nov 1, 2011, 00:00

  • PMS59 Inadequate Pain Relief in Knee Osteoarthritis and Patient Reported outcomes- A Survey of Osteoarthritis Real World Therapies (SORT) in the United Kingdom

    Nov 1, 2011, 00:00

  • PIH21 the Potential Public Health Benefit of Pneumococcal Conjugate Vaccines in the Kingdom of Saudi Arabia

    Nov 1, 2011, 00:00

  • PCN35 Capecitabine for the Treatment of Colorectal Cancer in Private Health System in Brazil- A Budgetary Impact Analysis Based on Real World Data

    Nov 1, 2011, 00:00

  • PCN11 Bevacizumab in Combination with Chemotherapy for the First-Line Treatment of Metastatic Colorectal Cancer

    Nov 1, 2011, 00:00

  • PRS6 Cost-Effectiveness of Fluticasone Furoate Compared with Mometasona Furoate for the Primary Treatment of Allergic Rhinitis Patients

    Nov 1, 2011, 00:00

  • PSY33 Clinical and Economic Analysis of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura in Context of Russian Health Care System

    Nov 1, 2011, 00:00

  • PSS39 Assessment of the Health Status Using the 12-Item Medical Outcomes Study Short Form (SF-12) Questionnaire (2578 Dermatological Out-Patients)

    Nov 1, 2011, 00:00

  • PMS74 Use of Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in Quebec, Canada

    Nov 1, 2011, 00:00

  • PHP138 Intangible Capital and Return on Assets in the Pharmaceutical Industry

    Nov 1, 2011, 00:00

  • PMS55 Persistence to Osteoporosis Treatment and its association to the Risk of Fracture Among Women in Taiwan

    Nov 1, 2011, 00:00

  • PSY8 Neuropathic Pain- a Budget Impact Analysis to Estimate Costs Due to the Introduction of Qutenza® on the Spanish Market

    Nov 1, 2011, 00:00

  • PND54 Quality of Life Impairment, Disability, and Economic Burden Associated with Chronic Daily Headache Focussing on Chronic Migraine With or Without Medication Overuse- A Systematic Review

    Nov 1, 2011, 00:00

  • PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) Deficiency

    Nov 1, 2011, 00:00

  • PCN187 Treatment Patterns in Patients with Metastatic Melanoma

    Nov 1, 2011, 00:00

  • PHP43 Exploring Social Determinants of the Health of International Immigrants in Chile- The Global Health Status Index

    Nov 1, 2011, 00:00

  • PCN160 Prostate Cancer Screening Practices in the Republic of Ireland- The Determinants of Uptake

    Nov 1, 2011, 00:00

  • PCV72 Long-Term Cost Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome from a Polish Health Care Perspective

    Nov 1, 2011, 00:00

  • PSU2 Comparison of Seizure and Hydrocephalus and Other Clinical Conditions Before and After Subependymal Giant Cell Astrocytoma Surgery in Patients with Tuberous Sclerosis Complex

    Nov 1, 2011, 00:00

  • PHP15 Implications of Latin American Pharmaceutical Pricing Reform for the UK NHS

    Nov 1, 2011, 00:00

  • PUK1 Comparison Of Direct Medical Cost Of Dialysis In A Mexican Cohort Either On Peritoneal Or Hemodialysis

    Nov 1, 2011, 00:00

  • PGI11 Cost Analysis of Antihelicobacter Therapy of Gastric and Duodenum Ulcer in Ukraine

    Nov 1, 2011, 00:00

  • PCN5 Reduced Risk of Chemotherapy-Induced Nausea and Vomiting in Patients with Cancer Treated with Highly Emetogenic Chemotherapy and Antiemetic Prophylaxis With Palonosetron

    Nov 1, 2011, 00:00

  • PSY39 Predictors of Health Utilities Among Patients with Rheumatoid Arthritis in Europe

    Nov 1, 2011, 00:00

  • PSY6 Estudio De COSTO-Efectividad De Buprenorfina TRANSDÉrmica Versus Oxicodona Oral Y Fentanilo TRANSDÉrmico En El Manejo Del Dolor CRÓnico No OncolÓgico En El Hospital San JosÉ De Bogotá D.C. Enero-Diciembre 2010

    Nov 1, 2011, 00:00

  • CN3 Cost Effectiveness of Liposomal Doxorubicin Versus Paclitaxel for the Treatment of Aids-Ks

    Nov 1, 2011, 00:00

  • PRS67 Consumption Patterns and in Vitro Resistance of S. Pneumoniae to Fluoroquinolones

    Nov 1, 2011, 00:00

  • PMD80 Patient Demographics and Surgical Expenditure in Hernia repair Surgical Cohorts Using A retrospective Nationwide Patient Database

    Nov 1, 2011, 00:00

  • PND44 Validation of the Fabry Outcome Survey (FOS) Paediatric Health and Pain Questionnaire

    Nov 1, 2011, 00:00

  • PCV3 Thromboprophylaxis Use and Venous Thromboembolism, Major and Minor Bleeding Event Analysis in Hospitalized Medically Ill Patients

    Nov 1, 2011, 00:00

  • PHP66 Impact of Type of Drug Insurance on the Use of Health Care Services Among Users of Antidepressants

    Nov 1, 2011, 00:00

  • HG2 Characterizing The Individual Course of Health-Related Quality of Life After Subarachnoid Hemorrhage

    Nov 1, 2011, 00:00

  • PHP29 Predictors of Appropriate Use of Insecticide Treated Nets in an Urban Community- The Case of Asokwa Sub-Metropolitan Area, Kumasi, Ashanti, Ghana

    Nov 1, 2011, 00:00

  • PCN7 Impacto Presupuestario Del Tratamiento En Primera LÍnea Para CÁncer Colorrectal MetastÁsico Basado En XELOX + anti-VEGF o XELOX + anti-EGFR

    Nov 1, 2011, 00:00

  • PHP29 Impact of Different Pharmaceutical Distribution Systems on the Access to Pharmaceutical Products in Six European Countries

    Nov 1, 2011, 00:00

  • PMD1 Nd-Yag Laser Incidence Rate Comparison of Three Monofocal Intraocular Lenses (IOL) 36 Months after Cataract Surgery in France

    Nov 1, 2011, 00:00

  • PRS16 Cost Analysis of Haemostatic Treatment with a Fibrin-Based Sponge Versus Fibrin Sealant in Lung Surgery and Liver Resection in a Spanish Setting

    Nov 1, 2011, 00:00

  • PIN61 Cost of Virologic Response with Two Active Drugs in the Optimized Background Therapy with Etravirine, Raltegravir, and Maraviroc in the Brazilian National AIDS Program

    Nov 1, 2011, 00:00

  • PHP123 To What Extent Does Advice from the Scottish Medicines Consortium (SMC) Agree with That Published by NICE?

    Nov 1, 2011, 00:00

  • PCV60 Cost-Effectiveness of Dabigatran for the Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Australia

    Nov 1, 2011, 00:00

  • PRM52 Socioeconomic Patterns Among International Immigrants in Chile- The Use of Clusters

    Nov 1, 2011, 00:00

  • PIH13 Generalising the Output of Rotavirus Vaccination Impact Studies- What Can We Learn?

    Nov 1, 2011, 00:00

  • Table of Contents

    Nov 1, 2011, 00:00

  • PRM48 A Model for Patients Accrual in Multi-Site Observational Studies- A Survival Analysis Approach

    Nov 1, 2011, 00:00

  • PHP149 Perception of Pharmaceutical Companies on the Drug Price-Volume Negotiation in South Korea

    Nov 1, 2011, 00:00

  • PSY24 Pregabalin is Cost-Saving in Comparison with Gabapentin Treated Patients when Added to Existing Therapy in the Management of Painful Radiculopathies

    Nov 1, 2011, 00:00

  • PHP25 Designing Feasible Models for an Optimal Pharmaceutical Consultation Program Using A Systematic Review

    Nov 1, 2011, 00:00

  • PHP134 Comparison of the Knowledge in Standard Treatment Guidelines among Medical Practitioners and Medical Students

    Nov 1, 2011, 00:00

  • CN2 Measuring Public Preferences For Colorectal Cancer Screening Using New Genome-Based Nanotechnologies

    Nov 1, 2011, 00:00

  • PIN105 Financial Support for HIV/AIDS Prevention, Care and Treatment in Thailand

    Nov 1, 2011, 00:00

  • PMS30 Cost-Effectiveness of Tocilizumab Compared to Standard Therapeutic Sequences for the Treatment of Moderate/Severe Rheumatoid Arthritis (RA) Patients in Portugal

    Nov 1, 2011, 00:00

  • PIN86 Interim Results on Adherence to Treatment of Chronic C Hepatitis Monoinfected and HCV/HIV Co-infected Patients Assessed by the Adhepta Questionnaire

    Nov 1, 2011, 00:00

  • PMD82 Drug Eluting Balloon for the Treatment of peripheral Artery Disease- A Cost-Effectiveness analysis in Italy

    Nov 1, 2011, 00:00

  • PIN108 Sustained Virological Response as Patient-Relevant Endpoint in Hepatitis C?

    Nov 1, 2011, 00:00

  • PHP25 Validity and Reliability of Instruments Used for Measuring Patient Satisfaction with Pharmaceutical Care Services

    Nov 1, 2011, 00:00

  • PRS8 Cost-Effectiveness of an Ambulatory program of Pulmonary rehabilitation following Acute Exacerbations of Copd in Colombia

    Nov 1, 2011, 00:00

  • PCN81 A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/NEU-Positive Breast Cancer in Colombia

    Nov 1, 2011, 00:00

  • PHP75 The Cost Per Day of Intensive Care Units (ICU) in Fran The CRRÉA Study

    Nov 1, 2011, 00:00

  • PIN97 How Does Health-Related Quality of Life Relate to Symptoms Experience in HIV Patients Treated with Highly-Active Antiretroviral Therapy?

    Nov 1, 2011, 00:00

  • PIH54 Analysis of the Formulary Ensure Children's Hospitals in Ukraine- First Results

    Nov 1, 2011, 00:00

  • PHP148 Global Pharmaceutical Risk-Sharing Agreement Trends in 2010 and 2011

    Nov 1, 2011, 00:00

  • PMD6 Efficacy and Safety of Artificial Disc Arthroplasty Compared to Surgical Fusion for Single Level Cervical and Lumbar Degenerative Disc Disease- A Bayesian Meta-analysis

    Nov 1, 2011, 00:00

  • PSY47 Evaluating the Cross-over Effect on Health-related Quality of Life in a Randomized Cross-over Study of Hemophilia-A Patients

    Nov 1, 2011, 00:00

  • PSS12 C-Reality (Canadian Burden of Diabetic Macular Edema Observational Study)- Three-Month Findings

    Nov 1, 2011, 00:00

  • PCN198 Review of Economic Assessments of Emerging Genomic Technologies in Oncology

    Nov 1, 2011, 00:00

  • PHP24 ComparaÇÃo Da qualidade De Vida Entre Pessoas Com DoenÇas Crónicas E Pessoas Da Comunidade Sem DoenÇa

    Nov 1, 2011, 00:00

  • PCN111 Cost-Effectiveness of Human Papillomavirus Vaccination for Prevention of Cervical Cancer in Roraima, A Brazilian Amazonic Region State

    Nov 1, 2011, 00:00

  • PCN167 National Formulary Review of the Drugs Used in Pancreatic Neuroendocrine Tumors in Korea

    Nov 1, 2011, 00:00

  • PHP42 Drug Consumption in Bosnia and Herzegovina - Comparison to Neighboring Country

    Nov 1, 2011, 00:00

  • PSY19 Economic Costs of Chemotherapy-Induced Febrile Neutropenia Among Patients with Non-Hodgkin'S Lymphoma in European Clinical Practice

    Nov 1, 2011, 00:00

  • PCN131 Systematic Evaluation of Specific Quality of Life Instruments for Prostate Cancer

    Nov 1, 2011, 00:00

  • PR1 Key Market Access Drivers for A Successful Health Technology Appraisal outcome – The Case of Rheumatoid Arthritis

    Nov 1, 2011, 00:00

  • PHP107 Clinical Trial Activity in Gree Opportunities Missed, Soon to be Forgone?

    Nov 1, 2011, 00:00

  • PSS37 the Clinical and Economic Burden of Acute Otitis Media- A Large Prospective Observational Cohort Study in Europe

    Nov 1, 2011, 00:00

  • PR3 Primary Health Care Evaluation in Chile- Patients’ Perspective

    Nov 1, 2011, 00:00

  • PDB82 Development of a Health Economic Model to Compare the Prevention, Treatment and Management Strategies of Type 2 Diabetes

    Nov 1, 2011, 00:00

  • PCV96 Cost-Utility Analysis of the Long-Term Cardiovascular Prevention Program in Russian Federation as an Argument for the Widespread Introduction of Preventive Technologies Into Clinical Practice

    Nov 1, 2011, 00:00

  • PND4 A Meta-analysis of the Duration of Clinical Effect of onabotulinumtoxina in Cervical Dystonia

    Nov 1, 2011, 00:00

  • PCN135 Influence of Economic Implications Related to the Prescription of Oral and Intravenous Chemotherapy on Physicians' Preferences- A Discrete Choice Experiment

    Nov 1, 2011, 00:00

  • PCV53 Cost Study of Caregiving for Patients with Chronic Symptomatic Heart Failure in Spain, Insights from the Inoescaro Study

    Nov 1, 2011, 00:00

  • PMH20 Health Care Cost Comparisons between Alcohol or Opioid- Dependent Patients Who Were Treated with Medication and Those Who Were Not

    Nov 1, 2011, 00:00

  • PDB71 Cross-Sectional Analysis of Ambulatory Care Expenditure Among Patients with Type 2 Diabetes Mellitus (T2DM) According to Treatment Stage and Renal Function in France Using EGB Database (Echantillon Generaliste De Beneficiaires)

    Nov 1, 2011, 00:00

  • PMS58 Pilot Validation of the Brief Fatigue Inventory ‘Fatigue at its Worst’ Item in Patients with Rheumatoid Arthritis

    Nov 1, 2011, 00:00

  • PHP5 Modelo Teorico De Un Consumidor- Seleccion Entre Un Biosimilar Y Un Biotecnologico De Patente Basado En Preferencias

    Nov 1, 2011, 00:00

  • PHP44 Inappropriate Prescriptions Based on Beers Criteria in Elderly Patients Treated at Home

    Nov 1, 2011, 00:00

  • PCN60 Economic Evaluation of Vaccination Against Cervical Cancer in the Moscow Region

    Nov 1, 2011, 00:00

  • PDB35 Estimating the Real Life Daily Usage and Daily Cost of GLP-1 Receptor Agonists in the UK Setting

    Nov 1, 2011, 00:00

  • PRS11 Budget Impact Analysis of Immunotherapy in Patients with Birch Allergic Rhinitis

    Nov 1, 2011, 00:00

  • PCN4 Costo-Efectividad De Octreotide Comparado Con Terapia De Soporte Usual Para El Tratamiento De Tumores Neuroendocrinos En Colombia

    Nov 1, 2011, 00:00

  • PMD18 Mast (Minimal Access Spinal Technologies) versus Open Surgery- Activity-Based Cost analysis of Spinal Fusion procedure from Hospital Perspective

    Nov 1, 2011, 00:00

  • PCN109 Cost Effectiveness of First Line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients- A Markov Model

    Nov 1, 2011, 00:00

  • PCN97 Economic Evaluation of Prophylactic Pegfilgrastim and Filgrastim in Patients with Myeloablative Chemotherapy to Avoid Neutropenia in the IMSS (Mexican Institute of Social Security)

    Nov 1, 2011, 00:00

  • PND53 The Patient-Reported Burden of Impaired Walking in Multiple Sclerosis

    Nov 1, 2011, 00:00

  • PCN137 Health State Utilities in Breast Cancer

    Nov 1, 2011, 00:00

  • PDB5 Use of a Discrete Event Simulation Model to Estimate Clinical and Economic Outcomes of Various Self-Monitoring of Blood Glucose Regimes Plus Conventional Pharmacologic Treatment on Type-2 Diabetic Patients in Mexico

    Nov 1, 2011, 00:00

  • PIH27 Potential Health and Economic Impact of Adding Rotarixtm to Routine Infant Vaccination Programs in Canada

    Nov 1, 2011, 00:00

  • PHP145 the Burden of Evidence in the Pharmaceutical Appraisal process

    Nov 1, 2011, 00:00

  • PHP26 Health Outcomes and Economics Research for Regenerative Medicine and Cellular Therapies- Lessons From A Multi-Market Health Technology Assessment and Reimbursement review

    Nov 1, 2011, 00:00

  • PCV44 Cost-Utility Associated with Different Monitoring Strategies Among Patients Receiving Long-Term Oral Anticoagulation Therapy in Austria

    Nov 1, 2011, 00:00

  • PSS40 The Effect of Acute Otitis Media in Children on Parents' Quality of Life- Development and Validation of A Questionnaire Implemented in A Prospective Observational Cohort Study in Europe

    Nov 1, 2011, 00:00

  • PHP104 Identifying Factors Influencing Drug Reimbursement in Scotland

    Nov 1, 2011, 00:00

  • PCV101 Population Based Study - Impact of Adherence to Antihypertensive Agents on Cardiovascular Issues

    Nov 1, 2011, 00:00

  • PSY54 A Cost Estimation of the New Guideline to Treat Bleeding Episodes in Patients with Haemophilia and Inhibitors in Iran

    Nov 1, 2011, 00:00

  • PMS68 Measuring the Health-Related Quality of Life in Patients with Rheumatoid Arthritis Treated with Adalimumab in Gree Comparing the Results of One Generic (EQ-5D) and One Disease-Specific (HAQ) Instrument

    Nov 1, 2011, 00:00

  • PHP90 The Reform of the Community Pharmacy in Italy Between New Role and Managerialism

    Nov 1, 2011, 00:00

  • PIH66 Trait or State- An Exploration of Self-Esteem, Happiness and Quality of Life by Time Series

    Nov 1, 2011, 00:00

  • CV1 A Cost-Utility Analysis of Prophylactic Therapy for Venous Thromboembolism with Dabigatran Etexilate or Enoxaparin

    Nov 1, 2011, 00:00

  • PCV118 Observational Study on the Treatment, Cost and Quality of Life of Subjects with Hereditary Angioedema

    Nov 1, 2011, 00:00

  • PHP53 Assessment of the Attitudes of the General Public Towards Supplementary Criteria to Be Used in PR Decision Making Process in Poland

    Nov 1, 2011, 00:00

  • PIH61 A qualitative Evaluation of the Integrated Management of Childhood Illness (IMCI) in Northeastern Brazil and Peru- The Managers' Perspective

    Nov 1, 2011, 00:00

  • PHP49 Developing Risk Sharing Arrangements – Potential for Brazil and Implications

    Nov 1, 2011, 00:00

  • PHP28 Decentralisation of Health Services Planning and Management- The Varying Perspectives of Health Workers and Community Members at Nanumba North District, Ghana

    Nov 1, 2011, 00:00

  • PMS32 Economic Analysis of Etanercept in Rheumatoid Arthritis from a Public perspective in Venezuela

    Nov 1, 2011, 00:00

  • Funding Linked to Ongoing Research- Impact of the Bosentan Patient Registry on Pricing in Australia

    Sep 1, 2011, 00:00

  • Economic Evaluation of Everolimus versus Sorafenib for the Treatment of Metastatic Renal Cell Carcinoma after Failure of First-Line Sunitinib

    Sep 1, 2011, 00:00

  • A New Validation of the Spanish Work Productivity and Activity Impairment Questionnaire—Crohn's Disease Version

    Sep 1, 2011, 00:00

  • Development and Validation of the SEC-QOL Questionnaire in Women Using Contraceptive Methods

    Sep 1, 2011, 00:00

  • Modelling Correlated Clinical Outcomes in Health Technology Appraisal

    Sep 1, 2011, 00:00

  • Cost-Effectiveness of a Recommendation of Universal Mass Vaccination for Seasonal Influenza in the United States

    Sep 1, 2011, 00:00

  • Consistency between Direct and Indirect Trial Evidence- Is Direct Evidence Always More Reliable?

    Sep 1, 2011, 00:00

  • Time Trade-Off Derived EQ-5D Weights for Australia

    Sep 1, 2011, 00:00

  • Differential Item Functioning in Quality of Life Measure between Children with and without Special Health-Care Needs

    Sep 1, 2011, 00:00

  • Table of Contents

    Sep 1, 2011, 00:00

  • Mapping FACT-Melanoma Quality-of-Life Scores to EQ-5D Health Utility Weights

    Sep 1, 2011, 00:00

  • Costs of Care for Dementia Patients in Community Setting- An Analysis for Mild and Moderate Disease Stage

    Sep 1, 2011, 00:00

  • Erratum

    Sep 1, 2011, 00:00

  • Instructions for Authors

    Sep 1, 2011, 00:00

  • A Trial-Based Assessment of the Cost-Utility of Bevacizumab and Chemotherapy versus Chemotherapy Alone for Advanced Non-Small Cell Lung Cancer

    Sep 1, 2011, 00:00

  • Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Chronic Kidney Disease Before and During Dialysis

    Sep 1, 2011, 00:00

  • Copyright/Subscription

    Sep 1, 2011, 00:00

  • Patient Access to New Cancer Drugs in the United States and Australia

    Sep 1, 2011, 00:00

  • Editorial Board

    Sep 1, 2011, 00:00

  • Comparison of the Underlying Constructs of the EQ-5D and Oxford Hip Score- Implications for Mapping

    Sep 1, 2011, 00:00

  • Cost-Effectiveness of Implantable Defibrillators after Myocardial Infarction Based on 8-Year Follow-Up Data (MADIT II)

    Sep 1, 2011, 00:00

  • How Valid and Responsive Are Generic Health Status Measures, such as EQ-5D and SF-36, in Schizophrenia? A Systematic Review

    Sep 1, 2011, 00:00

  • Esophageal Doppler Monitoring during Colorectal Resection Offers Cost-Effective Improvement of Hemodynamic Control

    Sep 1, 2011, 00:00

  • Patient Preference for Latent Tuberculosis Infection Preventive Treatment- A Discrete Choice Experiment

    Sep 1, 2011, 00:00

  • The Impact of a Revised EQ-5D Population Scoring on Preference-Based Utility Scores in an Inflammatory Arthritis Cohort

    Sep 1, 2011, 00:00

  • Impact of Measures to Enhance the Value of Observational Surveys in Rare Diseases- The Fabry Outcome Survey (FOS)

    Sep 1, 2011, 00:00

  • Measurement Equivalence of Interactive Voice Response and Paper Versions of the EQ-5D in a Cancer Patient Sample

    Sep 1, 2011, 00:00

  • Hospitalization Costs for Heart Failure in People with Type 2 Diabetes- Cost-Effectiveness of its Prevention Measured by a Simulated Preventive Treatment

    Jul 1, 2011, 00:00

  • Table of Contents

    Jul 1, 2011, 00:00

  • Bridging Trial and Decision- A Checklist to Frame Health Technology Assessments for Resource Allocation Decisions

    Jul 1, 2011, 00:00

  • Calibrating Longitudinal Models to Cross-Sectional Data- The Effect of Temporal Changes in Health Practices

    Jul 1, 2011, 00:00

  • Costos de la Esclerosis Múltiple en Colombia

    Jul 1, 2011, 00:00

  • Reviewer Acknowledgement

    Jul 1, 2011, 00:00

  • Factores Asociados al Incumplimiento de los Tratamientos con Antidepresivos en Santiago, Chile

    Jul 1, 2011, 00:00

  • Development and Validation of a Microsimulation Economic Model to Evaluate the Disease Burden Associated with Smoking and the Cost-Effectiveness of Tobacco Control Interventions in Latin America

    Jul 1, 2011, 00:00

  • Is Equity of Access to Health Care Achievable in Latin America?

    Jul 1, 2011, 00:00

  • Table of Contents

    Jul 1, 2011, 00:00

  • Evaluación Económica de un Programa de Inmunización Infantil en México Basado en la Vacuna Neumocócica Conjugada 13-Valente

    Jul 1, 2011, 00:00

  • Estimating the SF-6D Value Set for a Population-Based Sample of Brazilians

    Jul 1, 2011, 00:00

  • Development and Validation of the Influenza Intensity and Impact Questionnaire (FluiiQ™)

    Jul 1, 2011, 00:00

  • The Costs of Type 2 Diabetes Mellitus Outpatient Care in the Brazilian Public Health System

    Jul 1, 2011, 00:00

  • Ideal Vial Size for Bortezomib- Real-World Data on Waste and Cost Reduction in Treatment of Multiple Myeloma in Brazil

    Jul 1, 2011, 00:00

  • The Impact of Non-Severe Hypoglycemic Events on Work Productivity and Diabetes Management

    Jul 1, 2011, 00:00

  • Cost-Effectiveness of Supervised Exercise Therapy in Heart Failure Patients

    Jul 1, 2011, 00:00

  • Influence of Organic and Functional Dyspepsia on Work Productivity- The HEROES-DIP Study

    Jul 1, 2011, 00:00

  • Editorial Board

    Jul 1, 2011, 00:00

  • Survival Time Outcomes in Randomized, Controlled Trials and Meta-Analyses- The Parallel Universes of Efficacy and Cost-Effectiveness

    Jul 1, 2011, 00:00

  • Adjusting for Patient Crossover in Clinical Trials Using External Data- A Case Study of Lenalidomide for Advanced Multiple Myeloma

    Jul 1, 2011, 00:00

  • Cost Utility Analysis Based on a Head-to-Head Phase 3 Trial Comparing Ustekinumab and Etanercept in Patients with Moderate-to-Severe Plaque Psoriasis- A Canadian Perspective

    Jul 1, 2011, 00:00

  • Comparison of EQ-5D Scores among Anthracycline-Containing Regimens followed by Taxane and Taxane-Only Regimens for Node-Positive Breast Cancer Patients after Surgery- The N-SAS BC 02 Trial

    Jul 1, 2011, 00:00

  • Instructions for Authors

    Jul 1, 2011, 00:00

  • Implementing Pharmacoeconomic Guidelines in Latin America- Lessons Learned

    Jul 1, 2011, 00:00

  • Costo Efectividad de Posaconazol versus Fluconazol/Itraconazol en el Tratamiento Profiláctico de las Infecciones Fúngicas Invasivas en México

    Jul 1, 2011, 00:00

  • Precios de Referencia Internacional y Análisis de Costo Minimización para la Regulación de Precios de Medicamentos en Colombia

    Jul 1, 2011, 00:00

  • Chronic Hepatitis B Treatment- The Cost-Effectiveness of Interferon Compared to Lamivudin e

    Jul 1, 2011, 00:00

  • Insurance Status and Demographic and Clinical Factors Associated with Pharmacologic Treatment of Depression- Associations in a Cohort in Buenos Aires

    Jul 1, 2011, 00:00

  • Changes in Smokers' Attitudes Toward Intended Cessation Attempts in Japan

    Jul 1, 2011, 00:00

  • Costo-Efectividad del Cardiodesfibrilador Implantable en Pacientes con Factores de Riesgo de Muerte Súbita en Argentina

    Jul 1, 2011, 00:00

  • Análisis de la Satisfacción con los Cuidados en Salud a Través del Cuestionario EORTC IN-PATSAT32 en Pacientes con Cáncer de Mama, Linfoma no Hodgkin y Cáncer Colo-Rectal en Diferentes Etapas Clínicas. Relación con las Características Socio ...

    Jul 1, 2011, 00:00

  • Costo-Efectividad del Tratamiento de Salmeterol/Fluticasona en Comparación con Leucotrieno Montelukast para el Control del Asma Infantil

    Jul 1, 2011, 00:00

  • Instructions for Authors

    Jul 1, 2011, 00:00

  • The Use of a Decision Board to Elicit Brazilian Patients' and Physicians' Preferences for Treatment- The Case of Lupus Nephritis

    Jul 1, 2011, 00:00

  • Estimating Health State Utility Values for Comorbid Health Conditions Using SF-6D Data

    Jul 1, 2011, 00:00

  • Cost-Effectiveness Analysis of Linezolid, Daptomycin, and Vancomycin in Methicillin-Resistant Staphylococcus aureus- Complicated Skin and Skin Structure Infection Using Bayesian Methods for Evidence Synthesis

    Jul 1, 2011, 00:00

  • Development of a Transparent Interactive Decision Interrogator to Facilitate the Decision-Making Process in Health Care

    Jul 1, 2011, 00:00

  • Analysis of SF-6D Index Data- Is Beta Regression Appropriate?

    Jul 1, 2011, 00:00

  • Model-Based Economic Evaluation in Alzheimer's Disease- A Review of the Methods Available to Model Alzheimer's Disease Progression

    Jul 1, 2011, 00:00

  • Impact of Drug Treatment History on Comparative Effectiveness Research in Schizophrenia

    Jul 1, 2011, 00:00

  • Short-Term Therapy with Enoxaparin or Unfractionated Heparin for Venous Thromboembolism in Hospitalized Patients- Utilization Study and Cost-Minimization Analysis

    Jul 1, 2011, 00:00

  • Análise de Custo-Efetividade da Sinvastatina versus Atorvastatina na Prevenção Secundária de Eventos Cardiovasculares no Sistema Único de Saúde Brasileiro

    Jul 1, 2011, 00:00

  • Patrones de Tratamiento y Costo de Atención del Cáncer de Mama Avanzado Con Falla a Antraciclinas y Taxanos en 3 Hospitales Públicos de México

    Jul 1, 2011, 00:00

  • Health Status and Health Behaviors in Venezuelan Pharmacy Students

    Jul 1, 2011, 00:00

  • Evaluación de la Calidad de Vida en Pacientes con Linfoma no Hodgkin y Cáncer Colo-Rectal en Diferentes Etapas Clínicas Atendidos en el Instituto Mexicano del Seguro Social

    Jul 1, 2011, 00:00

  • Copyright/Subscription

    Jul 1, 2011, 00:00

  • Deriving a Preference-Based Measure for Cancer Using the EORTC QLQ-C30

    Jul 1, 2011, 00:00

  • Estimation and Comparison of EQ-5D Health States' Utility Weights for Pneumoccocal and Human Papillomavirus Diseases in Argentina, Chile, and the United Kingdom

    Jul 1, 2011, 00:00

  • Editorial Board

    Jul 1, 2011, 00:00

  • Incorporating Children's and Their Parents' Perspectives into Condition-Specific Quality-of-Life Instruments for Children with Cerebral Palsy- A Qualitative Study

    Jul 1, 2011, 00:00

  • Copyright/Subscription

    Jul 1, 2011, 00:00

  • Utility-Based Quality of Life of Overweight and Obese Adolescents

    Jul 1, 2011, 00:00

  • Costos de la Diabetes en Ameŕica Latina- Evidencias del Caso Mexicano

    Jul 1, 2011, 00:00

  • Pharmacoeconomics and Outcomes Research in Latin America- A Promising and Developing Field

    Jul 1, 2011, 00:00

  • 1st Special Issue- Pharmacoeconomics Outcomes Research in Latin America

    Jul 1, 2011, 00:00

  • Health-Related Quality of Life of Patients Recieving Hemodialysis and Peritoneal Dialysis in São Paulo, Brazil- A Longitudinal Study

    Jul 1, 2011, 00:00

  • Pharmacoeconomic Analysis of Capecitabine versus 5-Fluorouracil/Leucovorin as Adjuvant Therapy for Stage III Colon Cancer in Taiwan

    Jul 1, 2011, 00:00

  • Calidad de Vida en Mujeres Mexicanas con Cáncer de Mama en Diferentes Etapas Clínicas y su Asociación con Características Socio-Demográficas, Estados Co-Mórbidos y Características del Proceso de Atención en el Instituto Mexicano del Seguro ...

    Jul 1, 2011, 00:00

  • The Responsiveness of Quality of Life Utilities to Change in Depression- A Comparison of Instruments (SF-6D, EQ-5D, and DFD)

    Jul 1, 2011, 00:00

  • Evaluating Patient-Reported Outcome Measurement Comparability between Paper and Alternate Versions, Using the Lung Function Questionnaire as an Example

    Jul 1, 2011, 00:00

  • Cost-Effectiveness of Nucleoside Reverse Transcriptase Inhibitor Pairs in Efavirenz-Based Regimens for Treatment-Naïve Adults with HIV Infection in the United States

    Jul 1, 2011, 00:00

  • Health Care Resource Use and Costs in Opioid-Treated Patients with and without Constipation in Brazil

    Jul 1, 2011, 00:00

  • Gastos do Ministério da Saúde do Brasil com Medicamentos de Alto Custo- Uma Análise Centrada no Paciente

    Jul 1, 2011, 00:00

  • The Burden of Moderate/Severe Premenstrual Syndrome and Premenstrual Dysphoric Disorder in a Cohort of Latin American Women

    Jul 1, 2011, 00:00

  • The Long-Term Outcomes and Costs of Diabetes Mellitus among Renal Transplant Recipients- Tacrolimus versus Cyclosporine

    Jun 1, 2011, 00:00

  • Practical Implications of Differential Discounting in Cost-Effectiveness Analyses with Varying Numbers of Cohorts

    Jun 1, 2011, 00:00

  • Taking Conjoint Analysis to Task

    Jun 1, 2011, 00:00

  • Examining Web Equivalence and Risk Factor Sensitivity of the COPD Population Screener

    Jun 1, 2011, 00:00

  • Erratum

    Jun 1, 2011, 00:00

  • Impact of Depression on Work Productivity and Its Improvement after Outpatient Treatment with Antidepressants

    Jun 1, 2011, 00:00

  • Early Dialogue Between the Developers of New Technologies and Pricing and Reimbursement Agencies- A Pilot Study

    Jun 1, 2011, 00:00

  • Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies- Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices- Part 2

    Jun 1, 2011, 00:00

  • Economic Impact of Nonpersistence with Antidepressant Treatment in the Adult Population of Quebec- A Comparative Cost-Effectiveness Approach

    Jun 1, 2011, 00:00

  • Estimation of a Multiattribute Utility Function for the Spanish Version of the TooL Questionnaire

    Jun 1, 2011, 00:00

  • Cost-Effectiveness of Granulocyte Colony–Stimulating Factor Prophylaxis for Febrile Neutropenia in Breast Cancer in the United Kingdom

    Jun 1, 2011, 00:00

  • Ticagrelor versus Genotype-Driven Antiplatelet Therapy for Secondary Prevention after Acute Coronary Syndrome- A Cost-Effectiveness Analysis

    Jun 1, 2011, 00:00

  • Pharmaceutical Priority Setting and the Use of Health Economic Evaluations- A Systematic Literature Review

    Jun 1, 2011, 00:00

  • Editorial Board

    Jun 1, 2011, 00:00

  • Author Reply: Application of the Disease-Specific Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) Questionnaire in a General Population: Results from a French Panel Study

    Jun 1, 2011, 00:00

  • Using Health State Utility Values from the General Population to Approximate Baselines in Decision Analytic Models when Condition-Specific Data are Not Available

    Jun 1, 2011, 00:00

  • Perspectives on “Early Dialogue” between a Manufacturer and Health Technology Assessment Agencies

    Jun 1, 2011, 00:00

  • A Meta-Analysis of Osteoporotic Fracture Risk with Medication Nonadherence

    Jun 1, 2011, 00:00

  • Hospital Resource Utilization and Treatment Cost of Skeletal-Related Events in Patients with Metastatic Breast or Prostate Cancer- Estimation for the Portuguese National Health System

    Jun 1, 2011, 00:00

  • Instructions for Authors

    Jun 1, 2011, 00:00

  • Another Study Showing that Two Preference-Based Measures of Health-Related Quality of Life (EQ-5D and SF-6D) are Not Interchangeable. But Why Should We Expect Them to be?

    Jun 1, 2011, 00:00

  • The Use of Quality-Adjusted Life-Years in the Economic Evaluation of Health Technologies in Spain- A Review of the 1990–2009 Literature

    Jun 1, 2011, 00:00

  • Utility Scores and Treatment Preferences for Clinical Early-Stage Cervical Cancer

    Jun 1, 2011, 00:00

  • Patient-Reported Pediatric Quality of Life Inventory™ 4.0 Generic Core Scales in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder and Comorbid Psychiatric Disorders- Feasibility, Reliability, and Validity

    Jun 1, 2011, 00:00

  • The Chimera of Population Norms

    Jun 1, 2011, 00:00

  • Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making- Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices- Part 1

    Jun 1, 2011, 00:00

  • Economic Evaluation of Reamed versus Unreamed Intramedullary Nailing in Patients with Closed and Open Tibial Fractures- Results from the Study to Prospectively Evaluate Reamed Intramedullary Nails in Patients with Tibial Fractures (SPRINT)

    Jun 1, 2011, 00:00

  • Health Utilities Associated with Hemoglobin Levels and Blood Loss in Postmenopausal Women- The Women's Health Initiative

    Jun 1, 2011, 00:00

  • Copyright/Subscription

    Jun 1, 2011, 00:00

  • Table of Contents

    Jun 1, 2011, 00:00

  • ISPOR States Its Position on Network Meta-Analysis

    Jun 1, 2011, 00:00

  • Development of the EXACT-U- A Preference-Based Measure to Report COPD Exacerbation Utilities

    Jun 1, 2011, 00:00

  • The Association between Statin use and Outcomes Potentially Attributable to an Unhealthy Lifestyle in Older Adults

    Jun 1, 2011, 00:00

  • Conjoint Analysis Applications in Health—a Checklist- A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force

    Jun 1, 2011, 00:00

  • Trends in Health Care Utilization in British Columbia Following Public Coverage for Tiotropium

    Jun 1, 2011, 00:00

  • PMH77 UTILIZATION PATTERN OF PSYCHOTHERAPY AS AN ADJUNCT TO PHARMACOTHERAPY AMONG AMBULATORY BIPOLAR DISORDER PATIENTS

    May 1, 2011, 00:00

  • PIH45 MULTILEVEL ANALYSIS TO MEASURE HOSPITAL VARIATION- THE CASE OF CESAREAN DELIVERY

    May 1, 2011, 00:00

  • PMS7 THE IMPACT OF RHEUMATOID ARTHRITIS ON CARDIOVASCULAR MORBIDITY IN A HIGH RISK MEDICAID POPULATION

    May 1, 2011, 00:00

  • PCV101 EXPLORING GENDER DISPARITIES IN PREVENTIVE CARE UTILIZATION AMONGST THE UNITED STATES POPULATION

    May 1, 2011, 00:00

  • PGI25 STRUCTURED MANAGEMENT STRATEGY VERSUS USUAL PRIMARY CARE FOR GASTROESOPHAGEAL REFLUX DISEASE- META-ANALYSIS OF FIVE EUROPEAN CLUSTER RANDOMIZED TRIALS ASSESSING HEALTH CARE UTILIZATION COSTS

    May 1, 2011, 00:00

  • PND50 UNDERSTANDING HEALTH RELATED QUALITY OF LIFE CHANGES AND ISSUES RELATED TO DISEASE MODIFYING DRUGS AMONG MULTIPLE SCLEROSIS PATIENTS- A QUALITATIVE STUDY

    May 1, 2011, 00:00

  • PDB18 FACTORS ASSOCIATED WITH ROUTINE PROPER MONITORING OF DIABETES CARE AMONG THE NON-INSTITUTIONALIZED POPULATION IN THE UNITED STATES- A RETROSPECTIVE ANALYSIS OF THE 2007 MEDICAL EXPENDITURE PANEL SURVEY (MEPS)

    May 1, 2011, 00:00

  • PHP54 THE IMPACT OF PHARMACIST-CONDUCTED MEDICATION RECONCILIATION WITH PATIENT COUNSELING AT HOSPITAL ADMISSION

    May 1, 2011, 00:00

  • PCV13 BURDEN OF COMORBIDITIES AMONG PATIENTS WITH ATRIAL FIBRILLATION

    May 1, 2011, 00:00

  • PCN59 COST EFFECTIVENESS ANALYSIS OF LAPATINIB/CAPECITABINE (LC) VERSUS TRASTUZUMAB/CAPECITABINE (TC) IN PATIENTS WITH METASTATIC BREAST CANCER ERBB2+ AFTER PROGRESSION TO THE FIRST SCHEME OF TRASTUZUMAB

    May 1, 2011, 00:00

  • PCV99 MEDICAL RESOURCE UTILIZATION AND COSTS FOLLOWING HOSPITALIZATION OF PATIENTS WITH CHRONIC HEART FAILURE IN THE UNITED STATES

    May 1, 2011, 00:00

  • QA3 DOES COST-EFFECTIVENESS ANALYSIS DISCRIMINATE AGAINST PATIENTS WITH SHORTER LIFE EXPECTANCY?

    May 1, 2011, 00:00

  • PHP106 DISPARITY IN ACCESS TO NOVEL DIABETIC AGENTS FOR MEDICARE PART D ELDERLY COMPARED TO COMMERCIAL INSURED PATIENTS- INSIGHT INTO DOWNSTREAM EFFECTS OF CMS FORMULARY COVERAGE GUIDELINES FOR PDP'S

    May 1, 2011, 00:00

  • PCV76 PATIENT SYMPTOM EXPERIENCES FOLLOWING A MYOCARDIAL INFARCTION

    May 1, 2011, 00:00

  • PIH13 THE COST-EFFECTIVENESS OF THE LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM (LNG-IUS, MIRENA®) FOR THE TREATMENT OF HEAVY MENSTRUAL BLEEDING IN THE UNITED STATES

    May 1, 2011, 00:00

  • PIN12 ECONOMIC ANALYSIS OF CEFTIOFUR HYDROCHLORIDE FOR TREATMENT OF BOVINE CLINICAL MASTITIS CAUSED BY GRAM-NEGATIVE PATHOGENS IN DAIRY COWS IN THE UNITED STATES

    May 1, 2011, 00:00

  • PCV32 BUDGET IMPACT ANALYSIS OF INCREASING LMWH/FXI UTILIZATION

    May 1, 2011, 00:00

  • CO2 REAL-WORLD COST-EFFECTIVENESS ANALYSIS OF CANCER DRUGS- COMPARATIVE EFFECTIVENESS RESEARCH USING RETROSPECTIVE CANADIAN REGISTRY DATA BEFORE AND AFTER DRUG APPROVAL

    May 1, 2011, 00:00

  • PHP83 HTA DECISION DRIVERS FOR ACCEPTANCE OF HIGH ICER SUBMISSIONS AND REJECTION OF LOW ICER SUBMISSIONS

    May 1, 2011, 00:00

  • PRS38 EFFECT OF HAVING A PRESCRIPTION DRUG PLAN ON ASTHMA PATIENTS' USE OF CONTROLLER MEDICATIONS

    May 1, 2011, 00:00

  • PMH70 WHAT DROVE THE DRAMATIC SLOWDOWN IN PSYCHIATRIC DRUG SPENDING GROWTH IN THE UNITED STATES

    May 1, 2011, 00:00

  • PSY41 HEALTH-RELATED QUALITY OF LIFE IN KAZAKHSTAN PATIENTS WITH HEREDITARY COAGULOPATHIES

    May 1, 2011, 00:00

  • PGI26 PATIENT CHARACTERISTICS ASSOCIATED WITH USE OF ENTERAL VERSUS PARENTERAL ACID SUPPRESSIVE AGENTS IN INTENSIVE CARE UNIT PATIENTS

    May 1, 2011, 00:00

  • PRM25 PSYCHOMETRIC COMPARIBILITY OF SINGLE ITEM AND GRID FORM ADMINISTRATION OF THE SF-36V2™ HEALTH SURVEY

    May 1, 2011, 00:00

  • PCV55 COST-MINIMIZATION ANALYSIS OF THROMBOPROPHYLAXIS FOLLOWING ELECTIVE TOTAL HIP ARTHROPLASTY

    May 1, 2011, 00:00

  • PDB41 TREATMENT GAPS AMONG GROWTH HORMONE USERS IN A NATIONAL MANAGED CARE POPULATION IN THE UNITED STATES

    May 1, 2011, 00:00

  • PIH21 COST-UTILITY ANALYSIS OF DIENOGEST VERSUS GNRH ANALOGUE IN THE TREATMENT OF ENDOMETRIOSIS-ASSOCIATED PELVIC PAIN IN SLOVAKIA

    May 1, 2011, 00:00

  • PDB50 MEDICATION BELIEFS AMONG LOW-INCOME AFRICAN AMERICANS AND CAUCASIANS WITH DIABETES

    May 1, 2011, 00:00

  • PND54 RETROSPECTIVE DATABASE ANALYSIS OF FREQUENCY AND COSTS OF RELAPSES AMONG MULTIPLE SCLEROSIS PATIENTS

    May 1, 2011, 00:00

  • PMH65 EFFECT OF PRESCRIPTION MONITORING PROGRAMS (PMP'S) ON OPIOID OVERDOSE ADMISSION

    May 1, 2011, 00:00

  • PIN37 HOW MANY IMMUNIZATION DOSES WERE MISSED IN PEDIATRICES YOUNGER THAN 2 YEARS?

    May 1, 2011, 00:00

  • PMD14 COMPARISON OF PER DISCHARGE COSTS OF THE REPAIR OF INCISIONAL/VENTRAL HERNIAS PERFORMED WITH PERMACOL™ AND STRATTICE™ IN THE UNITED STATES

    May 1, 2011, 00:00

  • PCV82 EVALUATION OF RELATIONSHIP BETWEEN BLOOD PRESSURE CONTROL AMONG HYPERTENSIVE PATIENTS AND INTEGRATION OF SERVICES WITHIN PHYSICIAN ORGANIZATIONS

    May 1, 2011, 00:00

  • PMD20 COST-EFFECTIVENESS ANALYSIS OF A NEW INDEX FOR PROSTATE CANCER DETECTION

    May 1, 2011, 00:00

  • ISPOR 16TH Annual International Meeting Research Abstracts Author Index

    May 1, 2011, 00:00

  • PHP6 EXPLORE THE USE OF DRUGS IN MEDICAL INSURANCE BILLING IN CHINA

    May 1, 2011, 00:00

  • PRS40 TRENDS IN ANTIBIOTIC PRESCRIBING RATES IN AMBULATORY CARE SETTINGS FOR ADULTS IN THE UNITED STATES WITH NASOPHARYNGITIS, UPPER RESPIRATORY TRACT INFECTIONS AND BRONCHITIS FROM 2006 TO 2008

    May 1, 2011, 00:00

  • PCN99 ITALIAN MONITORING REGISTRY OF BEVACIZUMAB IN THE TREATMENT OF METASTATIC COLON RECTAL CARCINOMA

    May 1, 2011, 00:00

  • CE2 A NOVEL WAY OF ESTIMATING COST-EFFECTIVENESS RATIOS FROM CLINICAL TRIALS WITH MISSING DATA- A SIMULATION STUDY

    May 1, 2011, 00:00

  • PCN89 HTA AGENCIES' PREFERENCES REGARDING QUALITY OF LIFE MEASURES FOR PROSTATE CANCER CLINICAL TRIALS

    May 1, 2011, 00:00

  • PRS44 THE CHARIOT STUDY- NOVEL DATA COLLECTION, VIEWING AND DYNAMIC REPORTING MECHANISM

    May 1, 2011, 00:00

  • PSY61 CHARACTERISTICS OF GOLIMUMAB UTILIZATION AND COSTS IN A SPECIALTY PHARMACY PROVIDER (SPP) SETTING

    May 1, 2011, 00:00

  • PIH4 COMPARATIVE EFFECTIVENESS OF BANKED DONOR MILK FOR PREMATURE INFANTS- EFFICIENCY OF A MILK BANK MODEL INTEGRATED IN A BLOOD BANK SETTING

    May 1, 2011, 00:00

  • PGI20 IBS-C PATIENT SYMPTOM REPORTS- ANALYSIS OF EXPLORATORY OPEN-ENDED QUESTIONS

    May 1, 2011, 00:00

  • PMS2 ATRIAL FIBRILLATION IN OSTEOPOROTIC WOMEN TREATED WITH ALENDRONATE

    May 1, 2011, 00:00

  • PDB7 DIET THERAPIES IN PATIENTS WITH TYPE-2 DIABETES- A MIXED-TREATMENT COMPARISON OF RANDOMIZED CONTROL TRIALS

    May 1, 2011, 00:00

  • PMS30 COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS STANDARD CARE IN THE TREATMENT OF POST-MENOPAUSAL OSTEOPOROSIS IN PORTUGAL

    May 1, 2011, 00:00

  • PRS4 LITERATURE REVIEW OF RISK FACTORS FOR MORTALITY OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    May 1, 2011, 00:00

  • PHP46 THE STATE OF HEALTH ECONOMIC EVALUATION IN SOUTH AFRICA- A SYSTEMATIC REVIEW

    May 1, 2011, 00:00

  • PUK7 ECONOMIC EVALUATION OF CINACALCET VERSUS STANDARD TREATMENT IN PATIENTS WITH SECONDARY HYPERPARATHYROIDISM IN MEXICO

    May 1, 2011, 00:00

  • PHP11 REVIEW OF ADJUSTMENT OF ESSENTIAL MEDICINE LIST AT PROVINCIAL LEVEL IN CHINA

    May 1, 2011, 00:00

  • PSY11 BURDEN OF ILLNESS IN FIBROMYALGIA SYNDROME- THE PATIENTS' PERSPECTIVES

    May 1, 2011, 00:00

  • PMD4 PERCEPTION OF IRON DEFICIENCY IN CLINICAL PRACTICES- MULTIDISCIPLINARY FRENCH SURVEY (SUPFER SURVEY)

    May 1, 2011, 00:00

  • PHP61 WIDER CONSULTATION IN HEALTH TECHNOLOGY ASSESSMENT (HTA) DECISIONS- BETTER UNDERSTANDING OR A LOBBYING OPPORTUNITY?

    May 1, 2011, 00:00

  • PCN42 COSTS OF HOSPITAL EVENTS IN PATIENTS WITH METASTATIC COLORECTAL CANCER

    May 1, 2011, 00:00

  • PIN4 EFFICACY AND SAFETY OF THE COMBINATION EFAVIRENZ (EFV), TENOFOVIR (TDF) AND EMTRICITABINE (FTC) ONCE A DAY IN TREATMENT OF NAïVE ADULT PATIENTS WITH HIV-1 INFECTION- A SYSTEMATIC REVIEW

    May 1, 2011, 00:00

  • PMH10 THE INFLUENCE OF COMORBID ANXIETY ON MEDICATION USE AND SERVICE UTILIZATION AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER- RESULTS FROM A RETROSPECTIVE CLAIMS DATABASE

    May 1, 2011, 00:00

  • PDB71 CHARACTERISTICS OF EARLY ADOPTERS OF EXPENSIVE MEDICATIONS

    May 1, 2011, 00:00

  • PUK19 KIT73- PRELIMINARY REPORTS OF IMMUNOSUPRESSANT THERAPY PATTERNS IN A COHORT OF POST KIDNEY TRANSPLANT PATIENTS IN BRAZIL

    May 1, 2011, 00:00

  • PSY43 HEALTH-RELATED QUALITY OF LIFE IN UKRAINE PATIENTS WITH HEREDITARY COAGULOPATHIES

    May 1, 2011, 00:00

  • PIH16 COST-EFFECTIVENESS OF DESVENLAFAXINE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS IN BREAST CANCER PATIENTS IN MEXICO

    May 1, 2011, 00:00

  • PCV11 PNEUMONIA AFTER ACUTE ISCHEMIC STROKE- PREVALENCE, ASSOCIATED FACTORS AND OUTCOMES

    May 1, 2011, 00:00

  • PSY31 HEMOPHILIA A- PATIENT IMPACT AND ECONOMIC BURDEN OF THE DISEASE

    May 1, 2011, 00:00

  • PIH35 PHARMACISTS' ATTITUDE AND PREPAREDNESS REGARDING THE ISSUE OF ESCALATING PHARMACEUTICAL DEMAND DUE TO THE AGING BABY BOOMERS

    May 1, 2011, 00:00

  • PCN116 TRANSFERABILITY OF NICE RECOMMENDATIONS FOR PHARMACEUTICAL THERAPIES IN ONCOLOGY TO CENTRAL-EASTERN EUROPEAN COUNTRIES

    May 1, 2011, 00:00

  • PUK5 TREATMENT PATTERNS IN OVERACTIVE BLADDER- REAL-WORLD PATIENT POPULATION

    May 1, 2011, 00:00

  • PIN21 COST EFFECTIVENESS ANALYSIS OF VACCINATION PROGRAMS WITH 10-VALENT (PCV10) AND 13-VALENT (PCV13) PNEUMOCOCCAL VACCINES IN COLOMBIA

    May 1, 2011, 00:00

  • PCV42 A DECISION MODELING APPROACH TO EVALUATE THE COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH PLANNED PERCUTANEOUS CORONARY INTERVENTION

    May 1, 2011, 00:00

  • PSY13 THE COST OF OBESITY AND ITS MAJOR COMORBIDITIES- ANALYSIS FROM A COMMERCIAL CLAIMS DATABASE

    May 1, 2011, 00:00

  • SB1 COMPARISON OF DIFFERENCE-IN-DIFFERENCE, PROPENSITY SCORE MATCHING AND INSTRUMENTAL VARIABLES IN ESTIMATING COST DIFFERENCES BETWEEN TWO COHORTS

    May 1, 2011, 00:00

  • PSU10 COST-EFFECTIVENESS OF PRIMARY PCI WITHOUT ONSITE SURGICAL BACKUP

    May 1, 2011, 00:00

  • PRM24 EXPLORING THE INTERRELATIONSHIP BETWEEN UNINTENTIONAL AND INTENTIONAL NONADHERENCE AMONG 24,071 ADULTS WITH CHRONIC DISEASE

    May 1, 2011, 00:00

  • PHP44 DURATION OF PATIENTS VISITS TO THE EMERGENCY DEPARTMENT

    May 1, 2011, 00:00

  • PHP88 INFLUENCE OF HOSPITAL CHOICES OF DRUGS ON THE PHARMACEUTICAL CONSUMPTION IN THE COMMUNITY

    May 1, 2011, 00:00

  • PCN71 USING MEASURES OF SOCIETAL VALUE AND ECONOMIC MODELING TO ESTIMATE PRICES FOR CANCER DRUGS IN SOUTH AFRICA

    May 1, 2011, 00:00

  • PND6 THE IMPACT OF SPECIALTY CARE PROGRAMS ON RELAPSES OF MULTIPLE SCLEROSIS USING ADMINISTRATIVE DATA

    May 1, 2011, 00:00

  • PSY32 HOW DO MINIMALLY IMPORTANT DIFFERENCES VALUE OUTCOMES?

    May 1, 2011, 00:00

  • PMH49 CAN THE ILLNESS PERCEPTION QUESTIONNAIRE BE USED TO ASSESS MENTAL HEALTH PRACTITIONERS' PERSPECTIVES ON PATIENTS WITH SCHIZOPHRENIA?

    May 1, 2011, 00:00

  • PSU13 MORBID OBESITY AND HEALTH RELATED QUALITY OF LIFE

    May 1, 2011, 00:00

  • PCN73 UTILISATION OF ANTINEOPLASTIC AGENTS IN SLOVAK REPUBLIC

    May 1, 2011, 00:00

  • PMS21 ABATACEPT OR INFLIXIMAB FOR RHEUMATOID ARTHRITIS IN VENEZUELA? A COST-EFFECTIVENESS ANALYSIS

    May 1, 2011, 00:00

  • PSY60 ECONOMIC CONSEQUENCES OF UNDER-UTILIZATION WITH TUMOR NECROSIS FACTOR INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS

    May 1, 2011, 00:00

  • PCN100 RACIAL DISPARITIES IN AFRICAN AMERICAN VERSUS WHITE WOMEN WITH NEWLY DIAGNOSED BREAST CANCER IN A SOUTHEAST UNITED STATES HEALTH PLAN

    May 1, 2011, 00:00

  • PCV62 PERSISTENCE AND COMPLIANCE IN HYPERTENSION TREATMENT WITH OLMESARTAN MEDOXOMIL – ANALYSIS OF REAL-LIFE PRESCRIPTION DATA

    May 1, 2011, 00:00

  • PHP65 HEALTH OUTCOMES AND ECONOMICS RESEARCH FOR CELLULAR THERAPIES AND REGENERATIVE MEDICINES- LESSONS FROM A HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT ANALYSIS IN THE UNITED STATES

    May 1, 2011, 00:00

  • PCV78 HEALTH RELATED QUALITY OF LIFE IN HYPERTENSIVE PATIENTS VISITING PUBLIC HOSPITALS OF QUETTA, PAKISTAN

    May 1, 2011, 00:00

  • PSY45 CHARACTERISTICS OF CAREGIVERS AND THEIR EXPERIENCE ASSOCIATED WITH CONGENITAL HEMOPHILIA OF INHIBITOR PATIENTS

    May 1, 2011, 00:00

  • PDB12 USE OF ANTIDEPRESSANTS AND THE RISK OF DIABETES MELLITUS- A NESTED CASE-CONTROL STUDY

    May 1, 2011, 00:00

  • PMH37 THE COST-EFFECTIVENESS OF GUANFACINE EXTENDED RELEASE (GXR) VERSUS ATOMOXETINE (ATX) FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS

    May 1, 2011, 00:00

  • PMD30 IMPACT OF ACCESS TO A USUAL SOURCE OF CARE ON COMPLIANCE TO BREAST AND CERVICAL CANCER SCREENING

    May 1, 2011, 00:00

  • PMD12 GENDER DIFFERENCES IN TOTAL KNEE ARTHROPLASTY (TKA) POSTOPERATIVE PAIN MANAGEMENT IN THE UNITED STATES

    May 1, 2011, 00:00

  • PDB43 TREATMENT COMPLIANCE TO DIABETES CARE- A CROSS-SECTIONAL STUDY FROM PAKISTAN

    May 1, 2011, 00:00
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130 (current)
  • »